Stratagene Announces Third Quarter 2006 Earnings Release Date and Conference Call
November 06 2006 - 4:00PM
Business Wire
Stratagene Corporation (NASDAQ:STGN), today announced that it will
release third quarter financial results on Monday, November 13,
2006 after the market close. The Company will also host a
conference call and webcast on Monday, November 13, 2006 at 1:30
p.m. Pacific Time to discuss the Company�s third quarter results,
outlook for the remainder of 2006, and current corporate
developments. The dial-in number for the conference call is
800-218-8862 for domestic participants and 303-262-2142 for
international participants. A taped replay of the conference call
will also be available beginning approximately one hour after the
call�s conclusion and will remain available for 7 days. It can be
accessed by dialing 800-405-2236 for domestic callers and
303-590-3000 for international callers, using the passcode
11074147#. To access the live webcast of the call, go to
Stratagene�s website at www.stratagene.com and click on the
Investors icon. An archived webcast will also be available at
www.stratagene.com. About Stratagene Corporation Stratagene is a
developer, manufacturer and marketer of specialized life science
research and diagnostic products. The Company's life science
research unit supports advances in science by inventing,
manufacturing and distributing products that simplify, accelerate
and improve research. These products are used throughout the
academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery
and toxicology. The Company's diagnostic unit develops and
manufactures products for urinalysis as well as high quality
automated instrument and reagent systems that use blood samples to
test for more than 1,000 different allergies and autoimmune
disorders. In addition, by combining its expertise in diagnostics
and molecular biology, as well as its experience with FDA
regulatory procedures, the Company is pursuing opportunities to
expand its product portfolio to include molecular diagnostic kits
and instrumentation. More information is available at
www.stratagene.com. Stratagene Corporation (NASDAQ:STGN), today
announced that it will release third quarter financial results on
Monday, November 13, 2006 after the market close. The Company will
also host a conference call and webcast on Monday, November 13,
2006 at 1:30 p.m. Pacific Time to discuss the Company's third
quarter results, outlook for the remainder of 2006, and current
corporate developments. The dial-in number for the conference call
is 800-218-8862 for domestic participants and 303-262-2142 for
international participants. A taped replay of the conference call
will also be available beginning approximately one hour after the
call's conclusion and will remain available for 7 days. It can be
accessed by dialing 800-405-2236 for domestic callers and
303-590-3000 for international callers, using the passcode
11074147#. To access the live webcast of the call, go to
Stratagene's website at www.stratagene.com and click on the
Investors icon. An archived webcast will also be available at
www.stratagene.com. About Stratagene Corporation Stratagene is a
developer, manufacturer and marketer of specialized life science
research and diagnostic products. The Company's life science
research unit supports advances in science by inventing,
manufacturing and distributing products that simplify, accelerate
and improve research. These products are used throughout the
academic, industrial and government research sectors in fields
spanning molecular biology, genomics, proteomics, drug discovery
and toxicology. The Company's diagnostic unit develops and
manufactures products for urinalysis as well as high quality
automated instrument and reagent systems that use blood samples to
test for more than 1,000 different allergies and autoimmune
disorders. In addition, by combining its expertise in diagnostics
and molecular biology, as well as its experience with FDA
regulatory procedures, the Company is pursuing opportunities to
expand its product portfolio to include molecular diagnostic kits
and instrumentation. More information is available at
www.stratagene.com.
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From May 2024 to Jun 2024
Stratagene (NASDAQ:STGN)
Historical Stock Chart
From Jun 2023 to Jun 2024